Mayne Pharma Group Limited
ASX:MYX.AX
Overview | Financials
Company Name | Mayne Pharma Group Limited |
Symbol | MYX.AX |
Currency | AUD |
Price | 4.3 |
Market Cap | 365,819,490 |
Dividend Yield | 0% |
52-week-range | 3.52 - 7.46 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Shawn Patrick O'Brien B.Sc |
Website | https://www.maynepharma.com |
An error occurred while fetching data.
About Mayne Pharma Group Limited
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD